Protein MRI contrast agent with unprecedented metal selectivity and sensitivity for liver cancer imaging

With available MRI techniques, primary and metastatic liver cancers that are associated with high mortality rates and poor treatment responses are only diagnosed at late stages, due to the lack of highly sensitive contrast agents without Gd(3+) toxicity. We have developed a protein contrast agent (P...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:Proc Natl Acad Sci U S A
Główni autorzy: Xue, Shenghui, Yang, Hua, Qiao, Jingjuan, Pu, Fan, Jiang, Jie, Hubbard, Kendra, Hekmatyar, Khan, Langley, Jason, Salarian, Mani, Long, Robert C., Bryant, Robert G., Hu, Xiaoping Philip, Grossniklaus, Hans E., Liu, Zhi-Ren, Yang, Jenny J.
Format: Artigo
Język:Inglês
Wydane: National Academy of Sciences 2015
Hasła przedmiotowe:
Biological Sciences
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4450423/
https://ncbi.nlm.nih.gov/pubmed/25971726
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1423021112
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy